Showing 3 Result(s)

IntelGenx to Double in Value Next Year

On Thursday, IntelGenx, a drug delivery development company that produces and sells pharmaceutical films such as VersaFilm and transdermal VevaDerm, reported its Q4 full year 2020 financials, reporting fourth-quarter sales of $790,000 with an adjusted EBITDA loss of $754,000. After IntelGenx Technologies’ recent fourth-quarter report, Douglas Loe, an analyst at Leede Jones Gable, is optimistic …

Clarus Securities Pulls Back on StageZero Life Sciences

StageZero, headquartered in Richmond, Virginia, offers cancer and COVID-19 diagnostic tests and is promoting its Aristotle diagnostic tool as a multi-cancer blood screening. The company disclosed a purchase agreement to acquire Health Clinics Ltd (HCL), a telehealth company dealing with systemic inflammation and metabolic disorders. Following that, StageZero announced that Aristotle would be launched via …

Better Options to Pfizer Stock

COVID-19 has pushed drugmakers like Pfizer to the forefront of the global effort to find a cure for the pandemic, and its stock price has risen in a month or so after the company announced promising testing results for its COVID vaccine. Investors hoping for a large windfall from Pfizer, according to portfolio manager John …